Commentary on Robert Whitaker's viewpoint
Psychol Med
.
2020 Dec;50(16):2653-2654.
doi: 10.1017/S0033291720003591.
Epub 2020 Oct 26.
Authors
Jari Tiihonen
1
2
3
,
Heidi Taipale
1
2
4
,
Christoph U Correll
5
6
7
8
Affiliations
1
Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Niuvankuja 65, FI-70240Kuopio, Finland.
2
Department of Clinical Neuroscience, Karolinska Institutet, Tomtebodavägen 18A, 5th floor, SE-171 77Stockholm, Sweden.
3
Stockholm County Council, Stockholm Health Care Services, Norra Stationsgatan 69, SE-113 64Stockholm, Sweden.
4
School of Pharmacy, University of Eastern Finland, PO Box 1627, SE-70211Kuopio, Finland.
5
Division of Psychiatry Research, The Zucker Hillside Hospital, 75-59 263rd St, Glen Oaks, NY11004, USA.
6
Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY11550, USA.
7
The Feinstein Institute for Medical Research, Manhasset, NY11030, USA.
8
Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
PMID:
33100236
DOI:
10.1017/S0033291720003591
No abstract available
Publication types
Comment
MeSH terms
Antipsychotic Agents*
Humans
Syndrome
Substances
Antipsychotic Agents